Tonix Pharmaceuticals (TNXP) Reports Q3 Loss of $0.29/Share

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q3 EPS of ($0.29), versus ($0.72) reported last year.

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• DA Davidson Reiterates Neutral Rating on WW Grainger (GWW), Notes Tactical Upside Potential
• DigitalOcean projects record Q2 2026 results with RPO above $800M